The largest database of trusted experimental protocols

5 protocols using qpcr sybr green master mix

1

Characterizing Macrophage Activation and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Main instruments: Vernier caliper (Meinaite, Germany), Ultrasound imaging equipment (Vevo 3100), dehydrator, embedding machine, slicer, spreader (Leica, Germany), automatic tissue scanner (VS120, Olympus).
Main reagents: Cynarin (Chengdu Pufei De Biotechnology, 17041106), xylene (Sinopharm, 10023418), Ethylenediamine tetraacetic acid (Sinopharm. 10009617), 75%Ethanol (Sinopharm, 80176961), Absolute ethanol (Sinopharm, 10009218), Hematoxylin(sigma, H3136), Eosin Y (sigma, E4009), Monosodium Urate (sigma, U2875), Bovine Serum Albumin (Aladdin, B265994),Anti-F4/80 antibody (Abcam, ab6640), Macrophage-stimulating factor (MCSF) (Peprotech, 315–02), Anti-iNOS antibody (Abcam, ab3523), VECTASHIELD Mounting Medium with DAPI (Vectorlabs, H-1200), Trypsin antigen repair solution (Leagene Biotechnology, IH0310), Cell Counting Kit-8 (Dojindo laboratories, CK04), PrimeScript™ RT Reagent Kit (TaKaRa, RR037A), qPCR SYBR Green Master Mix (YESEN, 11201ES03), p-p65 antibody (CST, 3033), p65 antibody (CST, 8242), GAPDH antibody (sigma, G9545), p-p38 antibody (CST, 4511), p-IKKa/β antibody (CST, 2697),Anti-rabbit antibody (CST, 7074), p-JNK antibody (CST, 4668), p-ERK1/2 antibody (CST, 4370), Caspase 1/p20/p10 antibody (Proteintech, 22915-1-AP), Anti-NLRP3 antibody (Abcam, ab263899), Anti-IL-1β antibody (Abcam, ab200478).
+ Open protocol
+ Expand
2

Quantitative Expression Analysis of Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with an RNAprep Pure Plant Total RNA Extraction Kit (Tiangen Biotech, Co., Ltd., Beijing, China). Then, cDNA was acquired by reverse transcription of RNA samples with a cDNA Synthesis Kit (Yesen Biotech, Co., Ltd., Shanghai, China). The nucleic acid concentrations of total RNA and cDNA were determined from the A260 and A280 values by a NanoDrop 2000c (Thermo Fisher Scientific, Inc., Waltham, MA, United States). The primer sequences are listed in Supplementary Table S1. Each cDNA sample was used as a template and mixed with primers and qPCR SYBR® Green Master Mix (Yesen Biotech, Co., Ltd.). RT-PCR analysis was performed by iQ5 (Bio-Rad Laboratories, Inc., United States). To obtain relative gene expression for each sample, the threshold cycle (Ct) value was normalized to actin and compared to the control samples according to the 2-ΔΔCt method. Each sample was evaluated with three replications.
+ Open protocol
+ Expand
3

Differential RNA Expression in OA Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from the whole blood from the OA patients and healthy controls using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. Five genes (DVL1, WNT16, ITIH5, LRP1 and SFRP1) expression were detected by RT‐PCR with HifairTM first‐strand cDNA synthesis SuperMix and qPCR SYBR Green Master Mix (Yesen, Shanghai, China). Forward and reverse primers used for PCR were as follows: 5'‐CGTAAAGTGCTGGGGACCTT‐3', 5'‐GATCCACGCACTCAGGAACT‐3' (SFRP1); 5'‐TCCTCACTAACCAGCTCCGT‐3', 5'‐GCGCTCATGTCACTCTTCAC‐3' (DVL1); 5'‐CTACAGCTCCCTGCAAACGA‐3', 5'‐AGCACCAAGTTATCCCTCGC‐3' (WNT16); 5'‐GTCCCTGTGTGTGGGGTC‐3', 5'‐ACCCTGAGTCCATCCTGCTC‐3' (ITIH5); 5'‐CCGCTCTGATGAGTCTGCTT‐3', 5'‐AGTCATTGTCATTGTCGCATCT‐3' (LRP1); 5'‐GATGAGATTGGCATGGCTTT‐3', 5'‐GTCACCTTCACCGTTCCAGT‐3' (β‐actin). Statistical analysis used relative quantification, and the 2−△△CT method was used to calculate relative expression.
+ Open protocol
+ Expand
4

Childhood Atopic Dermatitis Risk Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected the following data via medical records and questionnaire investigation: age, gender, family history, feeding type (cow milk, breast milk, mixed), parent smoking, keeping pet, history of diseases, growth and development status, history of allergic. The questionnaire was screened according to Williams diagnostic criteria, and the patients with suspected AD were verified, diagnosed and counted by specialists according to the diagnostic criteria. IgE expression of cord blood was detected using immunofluorescence analysis, and interleukin-4, 5,10 were measured using the double antibody sandwich ELISA technique. The mRNA expression of VDR was detected RT-PCR with HifairTM first‐strand cDNA synthesis SuperMix and qPCR SYBR Green Master Mix (Yesen, Shanghai, China) using peripheral blood mononuclear cell: a plastic blood bag containing a blood sample into a centrifuge tube adapter, trim after centrifugation, remove the upper plasma layer will be removed in the middle of shallow to shallow layer was removed diluted with normal saline was added; the resulting product into a liquid containing lymphocyte separation centrifuge tube, wherein the product obtained is located in the upper lymphocyte separation medium; centrifugation, draw intermediate buffy coat washed, centrifuged supernatant was removed to obtain peripheral blood PBMC.
+ Open protocol
+ Expand
5

VDR Gene Expression in AR Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from whole blood from the AR patients and healthy controls using Trizol reagent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s instructions. VDR gene (Fok I) expression was determined using RT‐PCR with HifairTM first‐strand cDNA synthesis SuperMix and qPCR SYBR Green Master Mix (Yesen, Shanghai, China). The 2−ΔΔCT method was used to calculate relative expression.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!